

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.13963641 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.13963641 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.83865675 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.83865675 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.40538766 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.34627859 |
| 7 | * complement activation, alternative pathway (GO:0006957) | 6.17556559 |
| 8 | regulation of protein activation cascade (GO:2000257) | 6.08158367 |
| 9 | regulation of complement activation (GO:0030449) | 5.82827911 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.82715304 |
| 11 | protein carboxylation (GO:0018214) | 5.82715304 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.73408258 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.73408258 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.73408258 |
| 15 | regulation of mononuclear cell migration (GO:0071675) | 5.71991779 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.62074284 |
| 17 | urea cycle (GO:0000050) | 5.56558358 |
| 18 | urea metabolic process (GO:0019627) | 5.56558358 |
| 19 | bile acid biosynthetic process (GO:0006699) | 5.55914654 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.55902261 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51111074 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.44342678 |
| 23 | glyoxylate metabolic process (GO:0046487) | 5.41033923 |
| 24 | tryptophan metabolic process (GO:0006568) | 5.40269631 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.29791614 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 5.16252589 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.10320760 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.04820778 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.99354605 |
| 30 | cysteine metabolic process (GO:0006534) | 4.92415088 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.86274534 |
| 32 | glycosphingolipid catabolic process (GO:0046479) | 4.85187918 |
| 33 | response to peptidoglycan (GO:0032494) | 4.83990691 |
| 34 | bile acid metabolic process (GO:0008206) | 4.80115378 |
| 35 | phospholipid efflux (GO:0033700) | 4.78496297 |
| 36 | opsonization (GO:0008228) | 4.77385009 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.74486030 |
| 38 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.74401345 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.72900612 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.72244519 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.72244519 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72244519 |
| 43 | regulation of macrophage chemotaxis (GO:0010758) | 4.71839692 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.65450460 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 4.64989059 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.62811223 |
| 47 | neutrophil activation involved in immune response (GO:0002283) | 4.58412483 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.54674907 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.54674907 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.54077387 |
| 51 | regulation of apoptotic cell clearance (GO:2000425) | 4.52806563 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.49414960 |
| 53 | * complement activation (GO:0006956) | 4.49252949 |
| 54 | complement activation, classical pathway (GO:0006958) | 4.45626598 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.36430660 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.36430660 |
| 57 | glycolipid catabolic process (GO:0019377) | 4.35306550 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.34589165 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.31384006 |
| 60 | oligosaccharide catabolic process (GO:0009313) | 4.30267260 |
| 61 | cholesterol efflux (GO:0033344) | 4.29151382 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 4.26639573 |
| 63 | macrophage activation involved in immune response (GO:0002281) | 4.24605912 |
| 64 | lysine catabolic process (GO:0006554) | 4.24445255 |
| 65 | lysine metabolic process (GO:0006553) | 4.24445255 |
| 66 | amino sugar catabolic process (GO:0046348) | 4.23773645 |
| 67 | * protein activation cascade (GO:0072376) | 4.23215271 |
| 68 | bile acid and bile salt transport (GO:0015721) | 4.19109243 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.16580954 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 4.15956935 |
| 71 | cellular ketone body metabolic process (GO:0046950) | 4.12258544 |
| 72 | fibrinolysis (GO:0042730) | 4.11025183 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 4.07662582 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 4.02772862 |
| 75 | glycine metabolic process (GO:0006544) | 4.01643664 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 3.97784239 |
| 77 | glutamate metabolic process (GO:0006536) | 3.97205504 |
| 78 | cellular glucuronidation (GO:0052695) | 3.94728387 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.94464134 |
| 80 | ethanol oxidation (GO:0006069) | 3.94238620 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 3.93635330 |
| 82 | amine catabolic process (GO:0009310) | 3.93635330 |
| 83 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.93054752 |
| 84 | coenzyme catabolic process (GO:0009109) | 3.92449530 |
| 85 | regulation of humoral immune response (GO:0002920) | 3.88846830 |
| 86 | ceramide catabolic process (GO:0046514) | 3.86152499 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 3.84656764 |
| 88 | aldehyde catabolic process (GO:0046185) | 3.82601992 |
| 89 | arginine metabolic process (GO:0006525) | 3.82150090 |
| 90 | blood coagulation, intrinsic pathway (GO:0007597) | 3.80373372 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 3.79476822 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77606725 |
| 93 | serine family amino acid metabolic process (GO:0009069) | 3.76081006 |
| 94 | detection of molecule of bacterial origin (GO:0032490) | 3.71590269 |
| 95 | response to thyroid hormone (GO:0097066) | 3.71423859 |
| 96 | drug catabolic process (GO:0042737) | 3.71156259 |
| 97 | protein-lipid complex assembly (GO:0065005) | 3.70614856 |
| 98 | acute-phase response (GO:0006953) | 3.70396462 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.68924917 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.68047267 |
| 101 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67830658 |
| 102 | modulation by symbiont of host defense response (GO:0052031) | 3.67830658 |
| 103 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67830658 |
| 104 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67830658 |
| 105 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67830658 |
| 106 | modulation by symbiont of host immune response (GO:0052553) | 3.67830658 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.67269296 |
| 108 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.67082436 |
| 109 | positive regulation of mast cell degranulation (GO:0043306) | 3.67082436 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.64235401 |
| 111 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.63727653 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.63727653 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.62346082 |
| 114 | sterol homeostasis (GO:0055092) | 3.61191408 |
| 115 | monocyte chemotaxis (GO:0002548) | 3.59700022 |
| 116 | cofactor catabolic process (GO:0051187) | 3.57970575 |
| 117 | ketone body metabolic process (GO:1902224) | 3.55037312 |
| 118 | N-acetylneuraminate metabolic process (GO:0006054) | 3.54989862 |
| 119 | serine family amino acid biosynthetic process (GO:0009070) | 3.53992547 |
| 120 | eosinophil chemotaxis (GO:0048245) | 3.53678874 |
| 121 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52091112 |
| 122 | regulation of cholesterol storage (GO:0010885) | 3.51959943 |
| 123 | carboxylic acid catabolic process (GO:0046395) | 3.51357117 |
| 124 | organic acid catabolic process (GO:0016054) | 3.51357117 |
| 125 | T-helper 1 type immune response (GO:0042088) | 3.51182132 |
| 126 | positive regulation of leukocyte degranulation (GO:0043302) | 3.50647660 |
| 127 | uronic acid metabolic process (GO:0006063) | 3.50223348 |
| 128 | glucuronate metabolic process (GO:0019585) | 3.50223348 |
| 129 | lipoprotein metabolic process (GO:0042157) | 3.46870149 |
| 130 | barbed-end actin filament capping (GO:0051016) | 3.45797785 |
| 131 | protein-lipid complex subunit organization (GO:0071825) | 3.45525572 |
| 132 | regulation of mast cell degranulation (GO:0043304) | 3.41354976 |
| 133 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.41288968 |
| 134 | acetyl-CoA metabolic process (GO:0006084) | 3.40710103 |
| 135 | regulation of hypersensitivity (GO:0002883) | 3.38859748 |
| 136 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.34928172 |
| 137 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.33142027 |
| 138 | positive regulation of mast cell activation (GO:0033005) | 3.32365812 |
| 139 | cellular extravasation (GO:0045123) | 3.31390156 |
| 140 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.31017943 |
| 141 | macrophage activation (GO:0042116) | 3.26930911 |
| 142 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.26006587 |
| 143 | membrane lipid catabolic process (GO:0046466) | 3.24674110 |
| 144 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24314418 |
| 145 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.21927783 |
| 146 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.21236403 |
| 147 | eosinophil migration (GO:0072677) | 3.21097124 |
| 148 | myeloid dendritic cell differentiation (GO:0043011) | 3.19840286 |
| 149 | adenosine receptor signaling pathway (GO:0001973) | 3.16541750 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14338055 |
| 151 | microglial cell activation (GO:0001774) | 3.13648269 |
| 152 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.13554296 |
| 153 | apoptotic cell clearance (GO:0043277) | 3.12264415 |
| 154 | regulation of podosome assembly (GO:0071801) | 3.11863748 |
| 155 | sphingolipid catabolic process (GO:0030149) | 3.11020438 |
| 156 | granulocyte activation (GO:0036230) | 3.10357324 |
| 157 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.08922200 |
| 158 | virion attachment to host cell (GO:0019062) | 3.08083307 |
| 159 | adhesion of symbiont to host cell (GO:0044650) | 3.08083307 |
| 160 | B cell mediated immunity (GO:0019724) | 3.07704097 |
| 161 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07151763 |
| 162 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06022992 |
| 163 | regulation of leukocyte degranulation (GO:0043300) | 3.03959014 |
| 164 | detection of external biotic stimulus (GO:0098581) | 3.00919887 |
| 165 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.99626005 |
| 166 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97190977 |
| 167 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97095986 |
| 168 | macrophage differentiation (GO:0030225) | 2.95231057 |
| 169 | myeloid cell activation involved in immune response (GO:0002275) | 2.94713107 |
| 170 | histamine secretion (GO:0001821) | 2.92066591 |
| 171 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91915978 |
| 172 | myeloid dendritic cell activation (GO:0001773) | 2.90263995 |
| 173 | regulation of antigen processing and presentation (GO:0002577) | 2.89857265 |
| 174 | positive regulation of heat generation (GO:0031652) | 2.88509088 |
| 175 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88259600 |
| 176 | phagocytosis, engulfment (GO:0006911) | 2.86730982 |
| 177 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85334411 |
| 178 | regulation of interferon-alpha production (GO:0032647) | 2.84461338 |
| 179 | regulation of mast cell activation (GO:0033003) | 2.84287728 |
| 180 | detection of other organism (GO:0098543) | 2.84078893 |
| 181 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.83762126 |
| 182 | positive regulation of cholesterol efflux (GO:0010875) | 2.83286504 |
| 183 | pinocytosis (GO:0006907) | 2.82419126 |
| 184 | keratan sulfate catabolic process (GO:0042340) | 2.82294215 |
| 185 | regulation of chemokine biosynthetic process (GO:0045073) | 2.81779205 |
| 186 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.79835052 |
| 187 | adhesion of symbiont to host (GO:0044406) | 2.77029555 |
| 188 | negative regulation of granulocyte differentiation (GO:0030853) | 2.76243355 |
| 189 | phagosome maturation (GO:0090382) | 2.73531334 |
| 190 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73419414 |
| 191 | response to muramyl dipeptide (GO:0032495) | 2.73402095 |
| 192 | peptide catabolic process (GO:0043171) | 2.73182917 |
| 193 | cellular response to lipopolysaccharide (GO:0071222) | 2.72929237 |
| 194 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.72114897 |
| 195 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.71418687 |
| 196 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.70097579 |
| 197 | neutrophil chemotaxis (GO:0030593) | 2.68826602 |
| 198 | regulation of fever generation (GO:0031620) | 2.68117976 |
| 199 | cellular response to molecule of bacterial origin (GO:0071219) | 2.67753599 |
| 200 | detection of biotic stimulus (GO:0009595) | 2.67537520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.06468870 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.88192776 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.56150620 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.23024212 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.01080547 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.81036969 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63510124 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89413041 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.79552995 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76262427 |
| 11 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.47524274 |
| 12 | SPI1_23127762_ChIP-Seq_K562_Human | 2.34488194 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26303943 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.21755282 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14745704 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10737006 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10129421 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02510500 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4541797 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.98772854 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98325144 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93047585 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92981082 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89248570 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87901770 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84242445 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78654548 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76442598 |
| 29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75994333 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71078746 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.66158568 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58870302 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57918664 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52777090 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50629274 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49475830 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49071546 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43683530 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43111996 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36026190 |
| 41 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35890039 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35666416 |
| 43 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35147173 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33585308 |
| 45 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32914766 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31153107 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30426928 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30393439 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28408775 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27968844 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27029371 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26555099 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26479027 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26316150 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25589770 |
| 56 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25401991 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25306964 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23547300 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21663597 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19444003 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19175541 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18784070 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17219015 |
| 64 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12943559 |
| 65 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12474850 |
| 66 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11837103 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10782822 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.09163853 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07224526 |
| 70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06529052 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04864470 |
| 72 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00808976 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97750333 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97498193 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95073512 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94128453 |
| 77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93412399 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93227895 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92651155 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92475575 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92352969 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91846523 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91503375 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.91163842 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90804930 |
| 86 | * MYB_26560356_Chip-Seq_TH2_Human | 0.88692189 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88370795 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87368910 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85443580 |
| 90 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84593241 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82777384 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82101582 |
| 93 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81645024 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 0.80215911 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79232199 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78989754 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78060070 |
| 98 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77812832 |
| 99 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74099451 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73692597 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73489622 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72397133 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71786818 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70983910 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69952601 |
| 106 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69074101 |
| 107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68869962 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66768767 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66768767 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65663140 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65181200 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.65051588 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64111255 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64049638 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63917359 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62627026 |
| 117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.61657643 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.61387788 |
| 119 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61142937 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60507155 |
| 121 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.58883863 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57343368 |
| 123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57257106 |
| 124 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55843445 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54395184 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.53458940 |
| 127 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.52841633 |
| 128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51634567 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.51528589 |
| 130 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49869269 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.49253779 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49129010 |
| 133 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.48526368 |
| 134 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47448481 |
| 135 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.47278692 |
| 136 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.46276780 |
| 137 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.46161710 |
| 138 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.45584578 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.45539668 |
| 140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.45454461 |
| 141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.44972808 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43922453 |
| 143 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43725786 |
| 144 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.43454120 |
| 145 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.43366945 |
| 146 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.43035908 |
| 147 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.43029468 |
| 148 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42893290 |
| 149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42811410 |
| 150 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.42409694 |
| 151 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.41718190 |
| 152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41591756 |
| 153 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40636345 |
| 154 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40514540 |
| 155 | AR_20517297_ChIP-Seq_VCAP_Human | 0.40384809 |
| 156 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.39623921 |
| 157 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.39489962 |
| 158 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39214769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.82241919 |
| 2 | MP0005360_urolithiasis | 7.25080786 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.05120570 |
| 4 | MP0005365_abnormal_bile_salt | 5.85409058 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.95003301 |
| 6 | MP0009840_abnormal_foam_cell | 3.84222449 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.79107251 |
| 8 | MP0003252_abnormal_bile_duct | 3.61659159 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.57161869 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.18227923 |
| 11 | MP0005083_abnormal_biliary_tract | 2.98230844 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.89328039 |
| 13 | MP0000343_altered_response_to | 2.79028510 |
| 14 | MP0005332_abnormal_amino_acid | 2.72088496 |
| 15 | MP0003195_calcinosis | 2.71532815 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.63575546 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.56498108 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.40779422 |
| 19 | MP0005671_abnormal_response_to | 2.36915290 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.34971893 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 2.18776348 |
| 22 | MP0000609_abnormal_liver_physiology | 2.16730689 |
| 23 | MP0009278_abnormal_bone_marrow | 2.13885374 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.13538442 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.08636996 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.00046233 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.97754610 |
| 28 | MP0004510_myositis | 1.97622592 |
| 29 | MP0002998_abnormal_bone_remodeling | 1.88808340 |
| 30 | MP0002723_abnormal_immune_serum | 1.85092240 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.79714337 |
| 32 | MP0003868_abnormal_feces_composition | 1.70398498 |
| 33 | MP0001800_abnormal_humoral_immune | 1.69409265 |
| 34 | MP0001764_abnormal_homeostasis | 1.62323141 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.61379804 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.61379804 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.60834753 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56595342 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.53866864 |
| 40 | MP0001819_abnormal_immune_cell | 1.53804041 |
| 41 | MP0008004_abnormal_stomach_pH | 1.50759754 |
| 42 | MP0005310_abnormal_salivary_gland | 1.48554318 |
| 43 | MP0002405_respiratory_system_inflammati | 1.45533500 |
| 44 | MP0003448_altered_tumor_morphology | 1.43656446 |
| 45 | MP0005451_abnormal_body_composition | 1.43536820 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.42324223 |
| 47 | MP0000920_abnormal_myelination | 1.40393611 |
| 48 | MP0003828_pulmonary_edema | 1.38964793 |
| 49 | MP0000604_amyloidosis | 1.37658385 |
| 50 | MP0003011_delayed_dark_adaptation | 1.33469003 |
| 51 | MP0009697_abnormal_copulation | 1.29556344 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.24705225 |
| 53 | MP0000858_altered_metastatic_potential | 1.23814664 |
| 54 | MP0000598_abnormal_liver_morphology | 1.23148192 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.21852546 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.21786294 |
| 57 | MP0003436_decreased_susceptibility_to | 1.20209725 |
| 58 | MP0005164_abnormal_response_to | 1.19819980 |
| 59 | * MP0009763_increased_sensitivity_to | 1.16296872 |
| 60 | MP0003186_abnormal_redox_activity | 1.13498608 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.12661415 |
| 62 | MP0003724_increased_susceptibility_to | 1.11484543 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.09481395 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.09031022 |
| 65 | MP0006054_spinal_hemorrhage | 1.08401480 |
| 66 | MP0008469_abnormal_protein_level | 1.06611592 |
| 67 | MP0009764_decreased_sensitivity_to | 1.03655029 |
| 68 | MP0008260_abnormal_autophagy | 1.03435875 |
| 69 | MP0002254_reproductive_system_inflammat | 1.02474702 |
| 70 | MP0005165_increased_susceptibility_to | 1.02418048 |
| 71 | MP0005670_abnormal_white_adipose | 1.00515212 |
| 72 | MP0000716_abnormal_immune_system | 0.99572240 |
| 73 | MP0005464_abnormal_platelet_physiology | 0.97305812 |
| 74 | MP0001542_abnormal_bone_strength | 0.93205187 |
| 75 | MP0003075_altered_response_to | 0.92752624 |
| 76 | MP0003690_abnormal_glial_cell | 0.92712365 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.92116989 |
| 78 | MP0005647_abnormal_sex_gland | 0.91740230 |
| 79 | MP0003279_aneurysm | 0.88444659 |
| 80 | MP0005390_skeleton_phenotype | 0.88099935 |
| 81 | MP0003634_abnormal_glial_cell | 0.85478454 |
| 82 | MP0002090_abnormal_vision | 0.85470441 |
| 83 | MP0005595_abnormal_vascular_smooth | 0.85150067 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.82501063 |
| 85 | MP0003795_abnormal_bone_structure | 0.81247152 |
| 86 | MP0005408_hypopigmentation | 0.79241002 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.78917883 |
| 88 | MP0002933_joint_inflammation | 0.77840265 |
| 89 | MP0002277_abnormal_respiratory_mucosa | 0.77435000 |
| 90 | MP0003091_abnormal_cell_migration | 0.77065905 |
| 91 | MP0002971_abnormal_brown_adipose | 0.77041238 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.74758456 |
| 93 | MP0009053_abnormal_anal_canal | 0.73752050 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.73661381 |
| 95 | MP0004130_abnormal_muscle_cell | 0.73586920 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.72735019 |
| 97 | MP0002429_abnormal_blood_cell | 0.72484552 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.72192461 |
| 99 | MP0005535_abnormal_body_temperature | 0.71990373 |
| 100 | MP0003329_amyloid_beta_deposits | 0.71842018 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.70260231 |
| 102 | MP0005220_abnormal_exocrine_pancreas | 0.70146907 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.68587731 |
| 104 | MP0005334_abnormal_fat_pad | 0.68303815 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.67873318 |
| 106 | MP0003633_abnormal_nervous_system | 0.66939605 |
| 107 | MP0002398_abnormal_bone_marrow | 0.65945094 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.64523677 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.64453558 |
| 110 | MP0001663_abnormal_digestive_system | 0.64443962 |
| 111 | MP0002419_abnormal_innate_immunity | 0.62825528 |
| 112 | MP0004947_skin_inflammation | 0.62561758 |
| 113 | MP0001756_abnormal_urination | 0.62518382 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.62184184 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.61464339 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.60991974 |
| 117 | MP0000249_abnormal_blood_vessel | 0.60604810 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.60273170 |
| 119 | MP0001851_eye_inflammation | 0.60210345 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.59473223 |
| 121 | MP0005448_abnormal_energy_balance | 0.59383110 |
| 122 | MP0005166_decreased_susceptibility_to | 0.58104869 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.58010299 |
| 124 | MP0000371_diluted_coat_color | 0.57843051 |
| 125 | * MP0005025_abnormal_response_to | 0.56852912 |
| 126 | MP0000685_abnormal_immune_system | 0.56661616 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.56321325 |
| 128 | MP0002722_abnormal_immune_system | 0.56190709 |
| 129 | MP0001790_abnormal_immune_system | 0.56027682 |
| 130 | MP0005387_immune_system_phenotype | 0.56027682 |
| 131 | MP0005395_other_phenotype | 0.53151159 |
| 132 | MP0008873_increased_physiological_sensi | 0.52696049 |
| 133 | MP0008874_decreased_physiological_sensi | 0.52094259 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.51041117 |
| 135 | MP0001661_extended_life_span | 0.50244509 |
| 136 | MP0006082_CNS_inflammation | 0.49660180 |
| 137 | MP0002168_other_aberrant_phenotype | 0.48663693 |
| 138 | MP0005248_abnormal_Harderian_gland | 0.46094054 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.45453135 |
| 140 | MP0005023_abnormal_wound_healing | 0.45096010 |
| 141 | MP0005266_abnormal_metabolism | 0.45043872 |
| 142 | MP0002928_abnormal_bile_duct | 0.42995486 |
| 143 | MP0001853_heart_inflammation | 0.41317075 |
| 144 | MP0001915_intracranial_hemorrhage | 0.39295511 |
| 145 | MP0003303_peritoneal_inflammation | 0.38350453 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.38297399 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.37044765 |
| 148 | MP0004883_abnormal_blood_vessel | 0.36753507 |
| 149 | MP0003300_gastrointestinal_ulcer | 0.35914925 |
| 150 | MP0009785_altered_susceptibility_to | 0.35736678 |
| 151 | MP0002135_abnormal_kidney_morphology | 0.35356365 |
| 152 | MP0006035_abnormal_mitochondrial_morpho | 0.35153382 |
| 153 | MP0008438_abnormal_cutaneous_collagen | 0.35087667 |
| 154 | MP0009115_abnormal_fat_cell | 0.34999589 |
| 155 | MP0001243_abnormal_dermal_layer | 0.34008547 |
| 156 | MP0003953_abnormal_hormone_level | 0.33241823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 8.24986876 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.24986876 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.24986876 |
| 4 | Deep venous thrombosis (HP:0002625) | 7.83721390 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.93897908 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.80268804 |
| 7 | Complement deficiency (HP:0004431) | 6.78586115 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 6.62524106 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.26414152 |
| 10 | Xanthomatosis (HP:0000991) | 6.04679526 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 5.82657380 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 5.78068892 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 5.63480468 |
| 14 | Abnormality of complement system (HP:0005339) | 5.54816516 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 5.21588234 |
| 16 | Joint hemorrhage (HP:0005261) | 5.07794098 |
| 17 | Disinhibition (HP:0000734) | 5.01783872 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.89647201 |
| 19 | Dysostosis multiplex (HP:0000943) | 4.80453802 |
| 20 | Abnormality of macrophages (HP:0004311) | 4.75897666 |
| 21 | Glomerulonephritis (HP:0000099) | 4.72519366 |
| 22 | Mutism (HP:0002300) | 4.72092231 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.60051596 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 4.44504080 |
| 25 | Hypolipoproteinemia (HP:0010981) | 4.44363527 |
| 26 | Recurrent abscess formation (HP:0002722) | 4.43410130 |
| 27 | Loss of speech (HP:0002371) | 4.40743995 |
| 28 | Hyperammonemia (HP:0001987) | 4.23316080 |
| 29 | Epidermoid cyst (HP:0200040) | 4.14897574 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.07885601 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.98614643 |
| 32 | Neurofibrillary tangles (HP:0002185) | 3.94477146 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.93571632 |
| 34 | Eczematoid dermatitis (HP:0000976) | 3.91279056 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.90879870 |
| 36 | Ketosis (HP:0001946) | 3.84108341 |
| 37 | Hyperglycinemia (HP:0002154) | 3.80333927 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.76162396 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.76162396 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.76162396 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.74582973 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.74433534 |
| 43 | Axonal loss (HP:0003447) | 3.69674620 |
| 44 | Fat malabsorption (HP:0002630) | 3.66307874 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.64940136 |
| 46 | Nuclear cataract (HP:0100018) | 3.60189615 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.57029991 |
| 48 | Mucopolysacchariduria (HP:0008155) | 3.57029991 |
| 49 | Hypercholesterolemia (HP:0003124) | 3.57012585 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51112610 |
| 51 | Hypoglycemic coma (HP:0001325) | 3.45516725 |
| 52 | Hyperglycinuria (HP:0003108) | 3.40290257 |
| 53 | Abnormality of glycine metabolism (HP:0010895) | 3.38388145 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.38388145 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.38379276 |
| 56 | Spontaneous hematomas (HP:0007420) | 3.33857750 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.33586615 |
| 58 | Conjugated hyperbilirubinemia (HP:0002908) | 3.25659364 |
| 59 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.16622562 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 3.14344747 |
| 61 | Agnosia (HP:0010524) | 3.11946336 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.09952191 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 3.04660757 |
| 64 | Hyperbilirubinemia (HP:0002904) | 3.03532507 |
| 65 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00991510 |
| 66 | Nephritis (HP:0000123) | 2.98614017 |
| 67 | Apathy (HP:0000741) | 2.94074540 |
| 68 | Upper motor neuron abnormality (HP:0002127) | 2.94031887 |
| 69 | Myocardial infarction (HP:0001658) | 2.91068792 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 2.90354141 |
| 71 | Diminished motivation (HP:0000745) | 2.90104475 |
| 72 | Menorrhagia (HP:0000132) | 2.88292287 |
| 73 | Inappropriate behavior (HP:0000719) | 2.85606713 |
| 74 | Delayed CNS myelination (HP:0002188) | 2.85058263 |
| 75 | Orchitis (HP:0100796) | 2.84730144 |
| 76 | Purpura (HP:0000979) | 2.82583561 |
| 77 | Cerebral inclusion bodies (HP:0100314) | 2.80805083 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.78046601 |
| 79 | Myositis (HP:0100614) | 2.76706100 |
| 80 | Spontaneous abortion (HP:0005268) | 2.75929727 |
| 81 | Steatorrhea (HP:0002570) | 2.73812627 |
| 82 | Hematochezia (HP:0002573) | 2.73583149 |
| 83 | Hepatocellular carcinoma (HP:0001402) | 2.71388258 |
| 84 | Retinal atrophy (HP:0001105) | 2.70992573 |
| 85 | Ketoacidosis (HP:0001993) | 2.66055213 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65514878 |
| 87 | Stomatitis (HP:0010280) | 2.64545391 |
| 88 | Increased serum ferritin (HP:0003281) | 2.61809353 |
| 89 | Skin nodule (HP:0200036) | 2.61452290 |
| 90 | Optic neuritis (HP:0100653) | 2.61367735 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 2.61367735 |
| 92 | Abnormality of serum amino acid levels (HP:0003112) | 2.59861460 |
| 93 | Esophageal varix (HP:0002040) | 2.59289556 |
| 94 | Mitral stenosis (HP:0001718) | 2.58769111 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.53061144 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 2.51740022 |
| 97 | Hypochromic microcytic anemia (HP:0004840) | 2.49178274 |
| 98 | Gingival bleeding (HP:0000225) | 2.46128704 |
| 99 | Amyloidosis (HP:0011034) | 2.45033378 |
| 100 | Vascular calcification (HP:0004934) | 2.44361440 |
| 101 | Progressive neurologic deterioration (HP:0002344) | 2.41790584 |
| 102 | Recurrent skin infections (HP:0001581) | 2.41649722 |
| 103 | Metabolic acidosis (HP:0001942) | 2.36840950 |
| 104 | Obstructive lung disease (HP:0006536) | 2.36102634 |
| 105 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36102634 |
| 106 | Gingivitis (HP:0000230) | 2.35485018 |
| 107 | Personality changes (HP:0000751) | 2.34725675 |
| 108 | Metaphyseal irregularity (HP:0003025) | 2.34650152 |
| 109 | Dementia (HP:0000726) | 2.30799399 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27695672 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 2.27695672 |
| 112 | Spastic diplegia (HP:0001264) | 2.27078368 |
| 113 | Abnormal gallbladder morphology (HP:0012437) | 2.23764652 |
| 114 | Acanthocytosis (HP:0001927) | 2.21943489 |
| 115 | Irritability (HP:0000737) | 2.21910195 |
| 116 | Lethargy (HP:0001254) | 2.20523700 |
| 117 | Pathologic fracture (HP:0002756) | 2.20352573 |
| 118 | Hypoglycemic seizures (HP:0002173) | 2.19083700 |
| 119 | Hepatosplenomegaly (HP:0001433) | 2.18769791 |
| 120 | Cholelithiasis (HP:0001081) | 2.18246990 |
| 121 | Cholecystitis (HP:0001082) | 2.17846614 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 2.17846614 |
| 123 | Basal ganglia calcification (HP:0002135) | 2.16452498 |
| 124 | Thrombophlebitis (HP:0004418) | 2.15594416 |
| 125 | Cardiovascular calcification (HP:0011915) | 2.15526597 |
| 126 | Peripheral demyelination (HP:0011096) | 2.11722924 |
| 127 | Pulmonary infiltrates (HP:0002113) | 2.09449267 |
| 128 | Asymmetric septal hypertrophy (HP:0001670) | 2.08768490 |
| 129 | Prolonged neonatal jaundice (HP:0006579) | 2.08371104 |
| 130 | Conjunctival telangiectasia (HP:0000524) | 2.07476183 |
| 131 | Neonatal onset (HP:0003623) | 2.07228316 |
| 132 | Supranuclear gaze palsy (HP:0000605) | 2.05496121 |
| 133 | Petechiae (HP:0000967) | 2.04921442 |
| 134 | Gout (HP:0001997) | 2.04028628 |
| 135 | Abnormality of the periventricular white matter (HP:0002518) | 2.03844917 |
| 136 | Late onset (HP:0003584) | 2.00673548 |
| 137 | Hemorrhage of the eye (HP:0011885) | 1.99708039 |
| 138 | Progressive visual loss (HP:0000529) | 1.99522762 |
| 139 | Increased CSF protein (HP:0002922) | 1.97870119 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 1.97190718 |
| 141 | Cerebral edema (HP:0002181) | 1.97049153 |
| 142 | Peritonitis (HP:0002586) | 1.95477839 |
| 143 | Vertebral compression fractures (HP:0002953) | 1.92513002 |
| 144 | Global brain atrophy (HP:0002283) | 1.92113989 |
| 145 | Acute hepatic failure (HP:0006554) | 1.92031529 |
| 146 | Arthropathy (HP:0003040) | 1.91141360 |
| 147 | Hemoptysis (HP:0002105) | 1.91114479 |
| 148 | Pancreatitis (HP:0001733) | 1.90259393 |
| 149 | Abnormality of iron homeostasis (HP:0011031) | 1.89975287 |
| 150 | Malnutrition (HP:0004395) | 1.89857622 |
| 151 | Polyneuropathy (HP:0001271) | 1.89785407 |
| 152 | Cardiomegaly (HP:0001640) | 1.89232309 |
| 153 | Pulmonary embolism (HP:0002204) | 1.88801404 |
| 154 | Thoracic kyphosis (HP:0002942) | 1.88446489 |
| 155 | Memory impairment (HP:0002354) | 1.87537082 |
| 156 | Bone pain (HP:0002653) | 1.87477314 |
| 157 | Opisthotonus (HP:0002179) | 1.84150244 |
| 158 | Vacuolated lymphocytes (HP:0001922) | 1.84144694 |
| 159 | Vomiting (HP:0002013) | 1.82353440 |
| 160 | Abnormality of the gallbladder (HP:0005264) | 1.81433743 |
| 161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81370318 |
| 162 | Recurrent fungal infections (HP:0002841) | 1.79019348 |
| 163 | Keratoconjunctivitis sicca (HP:0001097) | 1.78964326 |
| 164 | Brushfield spots (HP:0001088) | 1.78534799 |
| 165 | Turricephaly (HP:0000262) | 1.77901265 |
| 166 | Epistaxis (HP:0000421) | 1.77704292 |
| 167 | Poikilocytosis (HP:0004447) | 1.76398651 |
| 168 | Enlarged kidneys (HP:0000105) | 1.75404457 |
| 169 | Premature loss of primary teeth (HP:0006323) | 1.72390283 |
| 170 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.71982182 |
| 171 | Generalized aminoaciduria (HP:0002909) | 1.70447207 |
| 172 | Urticaria (HP:0001025) | 1.70342376 |
| 173 | Elevated hepatic transaminases (HP:0002910) | 1.67235450 |
| 174 | Abnormal cartilage morphology (HP:0002763) | 1.66681835 |
| 175 | Meningitis (HP:0001287) | 1.66306887 |
| 176 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.65935348 |
| 177 | Nausea (HP:0002018) | 1.65533686 |
| 178 | Restrictive lung disease (HP:0002091) | 1.65335566 |
| 179 | Status epilepticus (HP:0002133) | 1.64692901 |
| 180 | J-shaped sella turcica (HP:0002680) | 1.64501705 |
| 181 | Rickets (HP:0002748) | 1.63954928 |
| 182 | Vasculitis (HP:0002633) | 1.63633296 |
| 183 | Bone cyst (HP:0012062) | 1.62282385 |
| 184 | Abnormality of the basal ganglia (HP:0002134) | 1.61633866 |
| 185 | Mucosal telangiectasiae (HP:0100579) | 1.61585616 |
| 186 | Keratoconjunctivitis (HP:0001096) | 1.59809995 |
| 187 | Pustule (HP:0200039) | 1.59076406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 5.37604874 |
| 2 | BCKDK | 5.21230041 |
| 3 | ERN1 | 4.52747757 |
| 4 | SIK1 | 3.53797805 |
| 5 | FGFR4 | 3.52600786 |
| 6 | TAOK3 | 3.36515090 |
| 7 | NME2 | 3.11868170 |
| 8 | GRK7 | 3.00216992 |
| 9 | DAPK2 | 2.64010114 |
| 10 | PKN2 | 2.63416063 |
| 11 | DDR2 | 2.56765050 |
| 12 | RIPK4 | 2.46648523 |
| 13 | TRIB3 | 2.42153962 |
| 14 | INSRR | 2.40991114 |
| 15 | CAMK1D | 2.15503451 |
| 16 | MET | 2.11402459 |
| 17 | MATK | 2.06723843 |
| 18 | TYK2 | 2.04063489 |
| 19 | TAOK2 | 1.91268670 |
| 20 | MAP2K4 | 1.90184590 |
| 21 | BLK | 1.78014256 |
| 22 | ERBB4 | 1.77723403 |
| 23 | RIPK1 | 1.67823251 |
| 24 | ACVR1B | 1.66610421 |
| 25 | PRPF4B | 1.66005437 |
| 26 | PTK6 | 1.63266729 |
| 27 | CAMKK2 | 1.56999511 |
| 28 | MOS | 1.52635752 |
| 29 | FLT3 | 1.48746639 |
| 30 | EPHB1 | 1.47646877 |
| 31 | GRK6 | 1.46154819 |
| 32 | CAMK1G | 1.43165293 |
| 33 | CDC42BPA | 1.40442126 |
| 34 | TAOK1 | 1.39852733 |
| 35 | MAPK11 | 1.34444589 |
| 36 | TBK1 | 1.29851066 |
| 37 | JAK3 | 1.28570724 |
| 38 | MAP2K3 | 1.25391799 |
| 39 | PIK3CG | 1.25079530 |
| 40 | PDK2 | 1.24185628 |
| 41 | PIM2 | 1.23501615 |
| 42 | BMPR2 | 1.20353692 |
| 43 | MAP4K1 | 1.19395233 |
| 44 | MAP3K7 | 1.18502343 |
| 45 | BMX | 1.15421401 |
| 46 | ADRBK2 | 1.15374860 |
| 47 | JAK1 | 1.12508922 |
| 48 | TGFBR2 | 1.11456074 |
| 49 | MAP3K11 | 1.10829988 |
| 50 | JAK2 | 1.09804532 |
| 51 | TXK | 1.08989723 |
| 52 | ABL2 | 1.08460168 |
| 53 | KDR | 1.06888987 |
| 54 | NEK9 | 1.00732368 |
| 55 | CSK | 1.00186225 |
| 56 | MAP3K10 | 0.97874736 |
| 57 | PRKAA2 | 0.97238761 |
| 58 | MAP3K14 | 0.95691258 |
| 59 | MAPK12 | 0.91697531 |
| 60 | CHUK | 0.79307918 |
| 61 | MAPK4 | 0.79172511 |
| 62 | TESK1 | 0.77884782 |
| 63 | TGFBR1 | 0.77786019 |
| 64 | MAP3K5 | 0.77496382 |
| 65 | IRAK2 | 0.76033430 |
| 66 | EPHA3 | 0.75976446 |
| 67 | LATS1 | 0.75813029 |
| 68 | MAP3K13 | 0.75276932 |
| 69 | CSF1R | 0.74763879 |
| 70 | ERBB2 | 0.74720718 |
| 71 | IRAK1 | 0.72290387 |
| 72 | TESK2 | 0.70369502 |
| 73 | PDGFRA | 0.70346651 |
| 74 | IGF1R | 0.69897645 |
| 75 | MARK3 | 0.69599045 |
| 76 | MAP3K3 | 0.67957760 |
| 77 | PRKCZ | 0.67170900 |
| 78 | FGFR2 | 0.65352857 |
| 79 | FRK | 0.64652043 |
| 80 | IKBKE | 0.62325637 |
| 81 | CAMKK1 | 0.62184711 |
| 82 | PRKACG | 0.61578346 |
| 83 | PAK4 | 0.61448066 |
| 84 | PDPK1 | 0.61259420 |
| 85 | KIT | 0.59736278 |
| 86 | PRKCH | 0.58947819 |
| 87 | EPHB2 | 0.58098427 |
| 88 | ZAP70 | 0.57091983 |
| 89 | ARAF | 0.55602788 |
| 90 | SGK3 | 0.55311994 |
| 91 | DAPK1 | 0.54647533 |
| 92 | PTK2 | 0.53254906 |
| 93 | RPS6KC1 | 0.53029549 |
| 94 | RPS6KL1 | 0.53029549 |
| 95 | GSK3A | 0.52498070 |
| 96 | CDK6 | 0.52182854 |
| 97 | FGFR3 | 0.51704643 |
| 98 | ABL1 | 0.51446674 |
| 99 | MAPK7 | 0.51117263 |
| 100 | RPS6KA2 | 0.50831698 |
| 101 | TYRO3 | 0.49994479 |
| 102 | MAP3K6 | 0.49422464 |
| 103 | EGFR | 0.49403337 |
| 104 | PINK1 | 0.49345706 |
| 105 | DYRK1B | 0.48668717 |
| 106 | IRAK3 | 0.47405094 |
| 107 | ITK | 0.47067278 |
| 108 | TNK2 | 0.46017215 |
| 109 | HCK | 0.44518143 |
| 110 | CDK4 | 0.43044345 |
| 111 | PDGFRB | 0.42665511 |
| 112 | CAMK4 | 0.42593053 |
| 113 | FGFR1 | 0.42368266 |
| 114 | RET | 0.41370210 |
| 115 | RPS6KA6 | 0.40867685 |
| 116 | PRKAA1 | 0.39661028 |
| 117 | PKN1 | 0.39010031 |
| 118 | PDK1 | 0.38865319 |
| 119 | MAP2K6 | 0.38753436 |
| 120 | PRKCQ | 0.37822399 |
| 121 | CAMK2G | 0.35811877 |
| 122 | INSR | 0.34850363 |
| 123 | STK38 | 0.34734555 |
| 124 | EPHA2 | 0.34514500 |
| 125 | BTK | 0.34414039 |
| 126 | PIM1 | 0.33859986 |
| 127 | MARK2 | 0.33767442 |
| 128 | LATS2 | 0.33734048 |
| 129 | DAPK3 | 0.33453875 |
| 130 | MAP3K1 | 0.32933234 |
| 131 | FES | 0.32871592 |
| 132 | PRKCD | 0.30930804 |
| 133 | LIMK1 | 0.30813262 |
| 134 | FYN | 0.30508796 |
| 135 | TIE1 | 0.30473401 |
| 136 | SIK2 | 0.30223587 |
| 137 | IRAK4 | 0.29342008 |
| 138 | PRKG2 | 0.27999297 |
| 139 | IKBKB | 0.27560043 |
| 140 | TEC | 0.27162384 |
| 141 | FGR | 0.23316513 |
| 142 | MTOR | 0.23029591 |
| 143 | LYN | 0.22674073 |
| 144 | ICK | 0.22559014 |
| 145 | STK10 | 0.22556810 |
| 146 | LCK | 0.20436310 |
| 147 | SYK | 0.20071125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.36785532 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70730392 |
| 3 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.37364038 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34644131 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28260334 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.22809224 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04592520 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.88421658 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.69358762 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.59622654 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58521861 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56305885 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45516231 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38338306 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33649953 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32350061 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 2.28135143 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.27614941 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.24841656 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24170490 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.22395066 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.18036677 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 2.10908488 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02476782 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01742049 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.98551211 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96455112 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95062115 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94795796 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91951011 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87281451 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83394375 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82888569 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81835404 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80129779 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79955643 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75783920 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72853426 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.71497887 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67694035 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66968587 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64918294 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61660088 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58216962 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.56098962 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53927788 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.53063211 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51855564 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51129205 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48923521 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.45813548 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44943101 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43456471 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40534492 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39846297 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39787628 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35978192 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33517204 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29815502 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29578063 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.27529418 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24169359 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21473084 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 1.19392332 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18649262 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17737943 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 1.17659920 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17545114 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15760206 |
| 70 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14787213 |
| 71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11942715 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10616715 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09880239 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07559760 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06372298 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02254036 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00588177 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98861450 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96239050 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96181755 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91810923 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91780421 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91352928 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88839931 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88226292 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87934327 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.86777434 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83540870 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82294694 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81374733 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78938359 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78183250 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75856039 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72926426 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.70329422 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69579091 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69255370 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.68594508 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68357488 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.67493959 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.64771993 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64007773 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63041150 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.62742044 |
| 105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62382321 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62152712 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59638013 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58872715 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58659294 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.56139117 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55043575 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54534129 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53927298 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52293752 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51922425 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51754585 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49282210 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45917519 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43723906 |
| 120 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42551672 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41700016 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40434177 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.40130840 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39079100 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37005581 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.36858190 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36227306 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35497726 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35181522 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32139380 |
| 131 | Pertussis_Homo sapiens_hsa05133 | 0.31217375 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30397814 |
| 133 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.29650701 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29200620 |
| 135 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26952967 |
| 136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26865750 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.26411613 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26019926 |
| 139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25668029 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22909028 |
| 141 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22425957 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22292102 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19733918 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19500076 |
| 145 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18534723 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17618999 |
| 147 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17569276 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.13442997 |
| 149 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.11410065 |
| 150 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11251191 |
| 151 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11057893 |
| 152 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.10725075 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09142345 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06467028 |
| 155 | Lysosome_Homo sapiens_hsa04142 | 0.05774266 |
| 156 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04871943 |
| 157 | Malaria_Homo sapiens_hsa05144 | 0.02606363 |
| 158 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1952200 |
| 159 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1730388 |
| 160 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1677352 |
| 161 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1470291 |
| 162 | Hepatitis C_Homo sapiens_hsa05160 | -0.1358036 |
| 163 | Leishmaniasis_Homo sapiens_hsa05140 | -0.1353791 |
| 164 | Legionellosis_Homo sapiens_hsa05134 | -0.1249347 |
| 165 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1144839 |
| 166 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1137356 |
| 167 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0976186 |
| 168 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0878170 |
| 169 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0812732 |
| 170 | Amoebiasis_Homo sapiens_hsa05146 | -0.0444270 |
| 171 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0360307 |
| 172 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0111252 |

